Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
4.53M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
275K
-
Shares change
-
-180K
-
Total reported value, excl. options
-
$462K
-
Value change
-
+$189K
-
Number of buys
-
1
-
Number of sells
-
-8
-
Price
-
$1.68
Significant Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) as of Q2 2025
9 filings reported holding PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value as of Q2 2025.
PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 275K shares
of 4.53M outstanding shares and own 6.07% of the company stock.
Largest 9 shareholders include Parallel Advisors, LLC (275K shares), Stonehage Fleming Financial Services Holdings Ltd (0 shares), AdvisorShares Investments LLC (0 shares), Virtu Financial LLC (0 shares), MORGAN STANLEY (0 shares), CITADEL ADVISORS LLC (0 shares), TWO SIGMA SECURITIES, LLC (0 shares), SABBY MANAGEMENT, LLC (0 shares), and UBS Group AG (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.